{Reference Type}: Journal Article
{Title}: Anti-HBc mirrors the activation of HBV-specific CD8+ T cell immune response and exhibits a direct effect on HBV control.
{Author}: Ye G;Chen C;Zhou Y;Tang L;Cai J;Huang Y;Yang J;Feng Y;Chen L;Wang Y;Ma Y;Lin G;Wu Y;Jiang X;Hou J;Li Y;
{Journal}: Antiviral Res
{Volume}: 230
{Issue}: 0
{Year}: 2024 Jul 31
{Factor}: 10.103
{DOI}: 10.1016/j.antiviral.2024.105975
{Abstract}: <B>BACKGROUND: </B>Hepatitis B core antibody (anti-HBc) is commonly present in patients with chronic hepatitis B virus (HBV) infection and serves as a marker of humoral immunity. Herein, we aim to investigate the correlation between anti-HBc and antiviral immune response and its putative role in HBV control.<BR><B>METHODS: </B>Quantitative anti-HBc and levels of anti-HBc subtypes were measured in chronic hepatitis B (CHB) patients. The effects of anti-HBc on immune cells and HBV replication were evaluated using the HBV mouse models and human hepatoma cell lines.<BR><B>RESULTS: </B>Baseline levels of IgG1 and IgG3 anti-HBc were elevated in CHB patients with favorable treatment response, and correlated with the virological response observed at week 52. Additionally, increased levels of IgM and IgG1 anti-HBc were observed exclusively in CHB patients with liver inflammation. Notably, significant correlations were identified between quantitative levels of anti-HBc and the frequencies of HBcAg-specific CD8+ T cells. Intriguingly, HBcAg efficiently activates T cells aided by B cells in vitro experiments. Moreover, anti-HBc inhibits HBV replication either by a direct effect or through complement-mediated cytotoxicity in HBV-producing cell lines.<BR><B>CONCLUSIONS: </B>Anti-HBc reflects the activation of an HBV-specific CD8+ T cell immune response and may have anti-HBV activity.